Sarcoidosis advanced registry study

This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.

This study looks at immune cells in the lungs, lymph nodes, and blood to learn more about suspected sarcoidosis. You may benefit by helping researchers better understand the condition and by getting close medical evaluation as part of the study.

This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.

This trial studies whether sirolimus (an immune-influencing medicine) can improve moderate-to-severe sarcoidosis affecting the face. It may help if you’ve tried standard sarcoidosis treatments before but they didn’t work well enough or stopped working.

This study follows adults with sarcoidosis to see which body “risk signals” (biomarkers) can predict whether the disease will get better or worse. It may help doctors monitor sarcoidosis more closely and choose the right treatment sooner.

This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.